4974 On Other Exchanges
Symbol
Exchange
4974 is not on other exchanges.

takara bio inc (4974) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TAKARA BIO INC (4974)

Related News

No related news articles were found.

takara bio inc (4974) Related Businessweek News

No Related Businessweek News Found

takara bio inc (4974) Details

Takara Bio Inc. operates as a biotechnology company in Japan, the United States, Asia, Europe, and internationally. It operates in three segments: Bio Industry, Gene Therapy, and AgriBio. The company develops research reagents and scientific instruments, such as restriction enzymes, PCR reagents, antibodies, cell culture media and gas-permeable bags, real-time PCR equipment, mass spectrometry systems, etc. It also provides research and contract manufacturing services comprising genome analysis, DNA chip analysis, IPS cell contract production services, cell processing and preparation, vector production, safety testing, technical support services for cancer immunotherapy, etc. In addition, the company engages in the development of various gene therapies, including HF10 anti-cancer therapy that is in Phase II clinical trials targeting malignant melanoma; siTCR gene therapy, which is in Phase I clinical trials for the treatment of esophageal cancer, synovial sarcoma, etc.; and MazF gene therapy, which is in Phase I clinical trials for patients infected with the human immunodeficiency virus. Further, it researches on functional properties derived from traditional Japanese food ingredients; and provides functional food ingredients as raw materials for foods, drinks, and cosmetics. Additionally, the company provides functional foods, such as Fucoidan from Gagome kombu, Isosamidin from herbs, Chalcone from Ashitaba, Agaro-oligosaccharide from Agar, Yamsgenin from the lesser yam, and Terpene from a mushroom. It also cultivates, produces, and markets various mushroom types, such as Honshimeji, Hatakeshimeji, and Bunashimeji, as well as licenses mushroom production technology. The company was founded in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.

1,273 Employees
Last Reported Date: 06/29/16
Founded in 2002

takara bio inc (4974) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

takara bio inc (4974) Key Developments

WaferGen Bio-systems, Inc. and Takara Bio Inc. Announce Exclusive Distribution Agreement for Japan

WaferGen Bio-systems, Inc. announced that it has entered into an exclusive distribution agreement in Japan with Takara Bio Inc. The agreement is for promotion and technical support of the ICELL8™ Single-Cell System, SmartChip™ Real-Time PCR, SmartChip™ Target Enrichment and Apollo 324™ products. WaferGen and Takara recently announced a merger agreement which is expected to close in March of 2017. The agreement includes the full Wafergen single-cell analysis and clinical research product lines. The ICELL8 Single-Cell System is a revolutionary system for single-cell analysis. It offers the unique ability to isolate thousands of single cells, automatically identify cells of interest, and prepare single-cells for NGS analysis. The system enables groundbreaking research in the areas of cancer, neuroscience, stem cell research and immunology. The SmartChip Real-Time PCR and SmartChip Target Enrichment systems are high throughput platforms used for clinical research applications, such as fast and efficient identification of variants associated with complex disease. The Apollo 324 system is a compact, highly flexible system for automated sample preparation for NGS.

Takara Bio Inc., Annual General Meeting, Jun 24, 2016

Takara Bio Inc., Annual General Meeting, Jun 24, 2016.

Takara Bio Inc. to Report Fiscal Year 2016 Results on May 09, 2016

Takara Bio Inc. announced that they will report fiscal year 2016 results on May 09, 2016

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4974 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4974.
View Industry Companies
 

Industry Analysis

4974

Industry Average

Valuation 4974 Industry Range
Price/Earnings 100.0x
Price/Sales 6.0x
Price/Book 3.0x
Price/Cash Flow 134.2x
TEV/Sales 5.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKARA BIO INC, please visit www.takara-bio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.